198 related articles for article (PubMed ID: 12234288)
1. Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells.
Okado T; Terada Y; Tanaka H; Inoshita S; Nakao A; Sasaki S
Kidney Int; 2002 Oct; 62(4):1178-86. PubMed ID: 12234288
[TBL] [Abstract][Full Text] [Related]
2. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
3. Involvement of p300 in TGF-beta/Smad-pathway-mediated alpha2(I) collagen expression in mouse mesangial cells.
Kanamaru Y; Nakao A; Tanaka Y; Inagaki Y; Ushio H; Shirato I; Horikoshi S; Okumura K; Ogawa H; Tomino Y
Nephron Exp Nephrol; 2003; 95(1):e36-42. PubMed ID: 14520013
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory smads and tgf-Beta signaling in glomerular cells.
Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
[TBL] [Abstract][Full Text] [Related]
5. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
[TBL] [Abstract][Full Text] [Related]
6. Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells.
Landström M; Heldin NE; Bu S; Hermansson A; Itoh S; ten Dijke P; Heldin CH
Curr Biol; 2000 May; 10(9):535-8. PubMed ID: 10801443
[TBL] [Abstract][Full Text] [Related]
7. Effects of all-trans retinoic acid on signal pathway of cyclooxygenase-2 and Smad3 in transforming growth factor-β-stimulated glomerular mesangial cells.
Han J; Zhang L; Chen X; Yang B; Guo N; Fan Y
Exp Biol Med (Maywood); 2014 Mar; 239(3):272-83. PubMed ID: 24500985
[TBL] [Abstract][Full Text] [Related]
8. Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis.
Zhao J; Crowe DL; Castillo C; Wuenschell C; Chai Y; Warburton D
Mech Dev; 2000 May; 93(1-2):71-81. PubMed ID: 10781941
[TBL] [Abstract][Full Text] [Related]
9. Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-beta -induced growth inhibition and apoptosis.
Patil S; Wildey GM; Brown TL; Choy L; Derynck R; Howe PH
J Biol Chem; 2000 Dec; 275(49):38363-70. PubMed ID: 10995749
[TBL] [Abstract][Full Text] [Related]
10. [Effect of transforming growth factor beta1/Smad signaling pathway on the expression and enzymatic activity of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in cultured rat mesangial cells].
Yang C; Dai L; Liu XG; Chen Q; Zhang XR; Guo MY
Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):553-7. PubMed ID: 14761603
[TBL] [Abstract][Full Text] [Related]
11. Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.
Li JH; Huang XR; Zhu HJ; Johnson R; Lan HY
Kidney Int; 2003 Jun; 63(6):2010-9. PubMed ID: 12753288
[TBL] [Abstract][Full Text] [Related]
12. Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells.
Lee HS; Moon KC; Song CY; Kim BC; Wang S; Hong HK
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F665-72. PubMed ID: 15198928
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
14. Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation.
Stopa M; Anhuf D; Terstegen L; Gatsios P; Gressner AM; Dooley S
J Biol Chem; 2000 Sep; 275(38):29308-17. PubMed ID: 10887185
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in podocytes induced by TGF-beta and Smad7.
Schiffer M; Bitzer M; Roberts IS; Kopp JB; ten Dijke P; Mundel P; Böttinger EP
J Clin Invest; 2001 Sep; 108(6):807-16. PubMed ID: 11560950
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2.
Wahab NA; Weston BS; Mason RM
Exp Cell Res; 2005 Jul; 307(2):305-14. PubMed ID: 15950619
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the effects of TGF-beta1 on mesangial cells by overexpression of Smad7.
Chen R; Huang C; Morinelli TA; Trojanowska M; Paul RV
J Am Soc Nephrol; 2002 Apr; 13(4):887-893. PubMed ID: 11912247
[TBL] [Abstract][Full Text] [Related]
19. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.
Chen Y; Blom IE; Sa S; Goldschmeding R; Abraham DJ; Leask A
Kidney Int; 2002 Oct; 62(4):1149-59. PubMed ID: 12234285
[TBL] [Abstract][Full Text] [Related]
20. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta.
von Gersdorff G; Susztak K; Rezvani F; Bitzer M; Liang D; Böttinger EP
J Biol Chem; 2000 Apr; 275(15):11320-6. PubMed ID: 10753944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
